GSK.L - LONDON STOCK EXCHANGE
Industry: Pharmaceuticals
Market Cap: 55.2 B
IPO Date: May 22, 1972
Country: GB
Currency: GBP
Shares Outstanding: 4.1 B
5/7/2025
2024 also saw some changes to some of my holdings as the author shuttled several dividend income payers for higher return crypto plays. Click to read.
Source: SeekingAlpha
5/5/2025
GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 numbers. Learn more about GSK stock here.
Source: SeekingAlpha
5/4/2025
GSK ( LON:GSK ) First Quarter 2025 Results Key Financial Results Revenue: UK£7.52b (up 2.1% from 1Q 2024). Net income...
Source: Yahoo
5/3/2025
The board of GSK plc ( LON:GSK ) has announced that it will pay a dividend on the 10th of July, with investors...
Source: Yahoo
5/1/2025
GSK PLC (GSK) reports a robust 17% increase in specialty medicines sales, while vaccine sales face a 6% decline, impacting overall performance.
Source: Yahoo
4/30/2025
The US risks being thrown into recession by Donald Trump’s trade war as official figures showed the economy shrank during the first three months of the year.
Source: Yahoo
4/30/2025
GSK stock jumped Wednesday after the British drugmaker said it's "well positioned" to respond if the U.S. levies tariffs on drug imports.
Source: Yahoo
4/30/2025
GSK (LSE:GSK) reported a significant improvement in its first-quarter earnings, with sales, net income, and earnings per share all showing promising growth. This announcement coincided with a 5.14% rise in GSK's shares over the past week. Meanwhile, broader market trends have been characterized by volatility, with the major indexes seeing declines following a weak GDP report. Despite these fluctuations, GSK's positive earnings report likely bolstered investor sentiment, helping the company to...
Source: Yahoo
4/30/2025
The American economy contracted by 0.3% in the first three months of the year amid Donald Trump’s threats of sweeping trade tariffs.
Source: Yahoo
4/30/2025
Uncertainty continues to hang over the latest round of financial results and forecasts for companies both big and small as they try to navigate a global trade system severely shaken by a shift in U.S. policy. Tariffs and the stark shift in policy has also shaken consumer and business confidence. The U.S. economy shrank during the first quarter of the year, its first drop in three years.
Source: Yahoo
4/30/2025
GSK plc (NYSE:GSK) Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ETCompany ParticipantsConstantin Fest - Head of IREmma Walmsley - CEOLuke Miels -...
Source: SeekingAlpha
4/30/2025
The latest investor updates on stocks that are trending on Wednesday.
Source: Yahoo
4/30/2025
Glaxo (GSK) delivered earnings and revenue surprises of 4.63% and 0.85%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Source: Yahoo
4/30/2025
It came as the FTSE 100 giant revealed a rise in sales as weakness in its vaccine division was offset by growth in speciality medicines.
Source: Yahoo
4/30/2025
GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand in the U.S.
Source: Yahoo
4/30/2025
GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts and dual sourcing for its medicines, but offered few details. The British drugmaker reported stronger-than-expected first-quarter results and reaffirmed its 2025 outlook, sending its shares up 3.8% by 0900 GMT. They were among the top gainers on London's FTSE 100 index, which was up 0.02%.
Source: Yahoo
4/29/2025
Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on SWTX and MKGAF stock post deal.
Source: SeekingAlpha
4/25/2025
We recently published a list of the 11 Best Undervalued UK Stocks to Buy Right Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best undervalued UK stocks to buy right now. The UK and Europe’s Performance in Q1 2025 The global markets entered 2025 […]
Source: Yahoo
4/25/2025
Earnings preview of key companies reporting next week and what to look out for.
Source: Yahoo
4/23/2025
Mounting evidence suggests that vaccination against the varicella zoster virus—which causes chickenpox in children and triggers shingles in adults—also protects the brain. Several recent studies suggest that the vaccines reduce the risk of dementia in older adults, but key questions remain, including: How the vaccines might work to stop or delay the condition, and whether the benefit is limited to people of a certain age. The vaccines studied, Zostavax and Shingrix, both appeared to offer protection.
Source: Yahoo